ANALYTICAL TESTING EDUCATION
How to Read a Peptide COA
Learn what common peptide test results can support — and what they cannot tell you by themselves.
A Certificate of Analysis can contain useful analytical information, but the title "COA" is not a scientific result by itself. Interpretation begins by asking what material was tested, which method was used, what result was obtained, and whether the report can be reliably connected to the sample or lot it represents.
Educational example — all names, lot numbers, analytical values, specifications, dates, laboratories, and results shown below are fictional.
Interactive COA document explorer
CERTIFICATE OF ANALYSIS — EDUCATIONAL EXAMPLE
NOT A REAL LABORATORY REPORT- Analyte
- Illustrative Peptide P-31
- Lot
- EDU-P31-260829-A
- Laboratory
- Northstar Analytical Sciences — fictional educational laboratory
- Report Date
- 2026-08-29
These values exist only to teach COA interpretation. They are not intended to represent typical peptide specifications, MitoCore specifications, regulatory limits, or results from an actual product.
1.Analyte / Product Name
Analyte / Product Name
This tells you what the report says was tested.
Analytical Question
What material does the paperwork claim to represent?
What this supports
- Document-level identification of the sample.
- Connection to a defined analytical target when supported by the rest of the report.
What this does not establish
- That the material is analytically confirmed to be that peptide.
- That the sample came from the claimed lot.
- Purity, content, sterility, endotoxin, or safety.
Illustrative Example
Illustrative Peptide P-31
2.Lot / Sample Identifier
Lot / Sample Identifier
A lot or sample number helps link the report to the material that was tested.
Analytical Question
Can this report be connected to a specific material or sample?
What this supports
- Traceability when the record system is reliable.
- Distinguishing one tested batch/sample from another.
What this does not establish
- Authenticity by itself.
- That the submitted sample actually came from the claimed production lot.
- Any analytical quality attribute.
Illustrative Example
EDU-P31-260829-A
View sources
- USPUSP — Reference Standards to Support Quality of Synthetic Peptide Therapeutics
- Editorial policyMitoCore Stage 25B scientific evidence boundary ruling (internal editorial policy, not a citation)
3.Laboratory
Laboratory
The laboratory name identifies who is reported to have performed the testing.
Analytical Question
Who performed the analytical work?
What this supports
- Identification of the reported testing organization.
What this does not establish
- That the laboratory is independent.
- That it is accredited for the specific method.
- That the report is authentic.
- That the sample chain is valid.
Illustrative Example
Northstar Analytical Sciences — fictional educational laboratory
View sources
- Editorial policyMitoCore Stage 25B scientific evidence boundary ruling (internal editorial policy, not a citation)
4.Test Method
Test Method
The method tells you how the laboratory answered a specific analytical question.
Analytical Question
How was this result generated?
What this supports
- Understanding what analytical question the result addresses.
- Assessing whether the method appears conceptually relevant to the claimed measurement.
What this does not establish
- That the method was executed correctly.
- That the method was validated or fit for every intended purpose.
- That results from a different method would be identical.
5.HPLC / UPLC Chromatographic Purity
HPLC / UPLC Chromatographic Purity
This describes how much of the detected chromatographic signal is associated with the main peptide peak under the stated method.
Analytical Question
How much of the detected chromatographic composition is represented by the main peptide component under this method?
What this supports
- Relative chromatographic composition.
- Assessment of detectable related substances when the method is suitable.
What this does not establish
- Absolute milligrams of peptide in the vial.
- Complete analytical identity.
- Sterility.
- Bacterial endotoxin status.
- Biological potency.
- Clinical safety.
Required context
99.2% chromatographic purity does NOT automatically mean that 99.2% of the labeled milligrams are present in the vial.
Illustrative Example
99.2% area
6.Mass Spectrometry / Identity
Mass Spectrometry / Identity
Mass spectrometry can show whether the measured molecular mass is consistent with the peptide expected to be present.
Analytical Question
Is the observed analytical mass consistent with the expected peptide?
What this supports
- Molecular-mass consistency with the expected analyte.
- Identity characterization.
- Characterization of certain related species depending on method.
What this does not establish
- Total vial content.
- Universal purity.
- Sterility.
- Endotoxin status.
- Clinical safety.
Required context
"Expected mass matches observed mass" is stronger than no identity test at all, but it is not a universal certificate of everything about the sample.
Illustrative Example
Expected 4,112.2 Da / Observed 4,112.3 Da
7.Assay / Content / Strength
Assay / Content / Strength
This answers a different question from chromatographic purity: how much peptide is actually present according to the quantitative method.
Analytical Question
How much peptide is present?
What this supports
- Quantitative peptide amount or strength under the defined method.
- Comparison with a labeled or target content specification.
What this does not establish
- Sterility.
- Endotoxin status.
- Complete impurity identification.
- Clinical safety.
Required context
Purity asks "What fraction of the detected chromatographic signal is the main component?" Assay asks "How much peptide is actually present?"
Illustrative Example
10.1 mg per vial
8.Specification / Acceptance Criterion
Specification / Acceptance Criterion
A specification defines the range or condition that a result is expected to meet.
Analytical Question
What result is considered acceptable under this testing framework?
What this supports
- Clear interpretation of pass/fail or conformance.
- Consistent decision-making when scientifically justified.
What this does not establish
- That the specification is appropriate merely because it appears on a COA.
- That a universal peptide standard exists for every test.
Illustrative Example
≥ 98.0% chromatographic area
9.Sterility
Sterility
Sterility testing looks for evidence of viable contaminating microorganisms under the conditions of the test.
Analytical Question
Did the sample meet the stated sterility-test criterion?
What this supports
- The sterility-test result within the specific sample, method, and test context.
What this does not establish
- Absence of bacterial endotoxin.
- Peptide identity.
- Chromatographic purity.
- Labeled peptide quantity.
- Clinical safety.
Required context
Sterility and endotoxin are not the same test.
Illustrative Example
No growth observed — fictional educational result
10.Bacterial Endotoxins
Bacterial Endotoxins
Endotoxin testing measures bacterial endotoxin contamination using a method designed for that purpose.
Analytical Question
What is the bacterial endotoxin result?
What this supports
- Endotoxin level or conformance under the specified method.
What this does not establish
- Sterility.
- Peptide identity.
- Purity.
- Labeled peptide content.
- Clinical safety.
Required context
A sample can pass one microbiological quality test without that result logically substituting for another.
Illustrative Example
0.8 EU/mg — fictional educational result
View sources
11.Residual Moisture
Residual Moisture
For a lyophilized material, residual moisture measures how much water remains after drying.
Analytical Question
How much residual water remains in the dried material?
What this supports
- Characterization of the lyophilized product's moisture content.
- Stability-related assessment when a justified specification exists.
What this does not establish
- Peptide identity.
- Chromatographic purity.
- Sterility.
- Endotoxin status.
- Universal storage life.
Illustrative Example
1.4% — fictional educational result
View sources
- Peer-reviewedMcCarthy D et al. — Reference Standards to Support Quality of Synthetic Peptide Therapeutics
- Peer-reviewedDesigning Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review
- Peer-reviewedFactors affecting the physical stability (aggregation) of peptide therapeutics
12.Report Date
Report Date
The report date tells you when the analytical report was issued or finalized.
Analytical Question
When was this report issued?
What this supports
- Timeline/context.
- Record traceability.
What this does not establish
- Sample authenticity.
- Product freshness or stability by itself.
- Analytical quality by itself.
Illustrative Example
2026-08-29
View sources
- Editorial policyMitoCore Stage 25B scientific evidence boundary ruling (internal editorial policy, not a citation)
Purity
“What fraction of detected chromatographic signal is the main component?”
99.2% area
Content
“How much peptide is present?”
10.1 mg per vial
NOT THE SAME QUESTION
99.2% chromatographic purity does NOT automatically mean that 99.2% of the labeled milligrams are present in the vial.
Sterility
- viable microorganisms
- dedicated microbiological test
Endotoxin
- bacterial endotoxin contamination
- separate dedicated test
Sterility and endotoxin are not the same test.
A COA Is Evidence — Not Magic
A useful COA can tell you a great deal, but only when the sample identity, testing method, result, specification, laboratory, and report can be trusted and connected to the material represented.
Not simply
“Does it have a COA?”
Ask instead
- What was tested?
- Which method was used?
- What does that method actually measure?
- What result was obtained?
- What specification was applied?
- Can the report be connected to the sample or lot?
- What important quality questions were not tested?
This page uses fictional educational values and does not display results from a real MitoCore product, laboratory, or lot.